Login

From the Helm: Lindsay Partridge on Brickworks' Growth and Dividend Success | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Anton Paar Discusses Collaboration and Innovation in Battery Industry Transitions
00:10:00
Nils Brauckmann's Debut as SUSE CEO – Key Highlights and Vision | Nils Brauckmann ,CEO , SUSE SA.
00:10:00
I speak with RingCentral Founder Vlad Shmunis and CEO Tarek Robbiati about how the platform will differentiate itself in a crowded market.
00:10:00
A financial advisor with Trustmark National Bank, providing expertise in investment strategies through Trustmark Investment Advisors, Inc.
00:10:00
Involvement inventing the breast cancer drug Herceptin and discussed the investment offering for his latest therapeutic development company|H. Michael Shepard , CEO OF ENOSI THERAPEUTICS
00:10:00
"S.C. Parker & Co., Inc.: A Legacy of Independent Investment and Holistic Financial Planning"
00:00:00
Jon Pilcher, CEO, Neuren Pharmaceuticals Ltd
00:10:00
Anthony from Linden Thomas & Company: Commitment to Clients Matters
00:10:00
Unlocking Opportunity: Nicole Hunter on Dimensional’s ETF Strategy | Nicole Hunter – Head of ETF Capital Markets, Dimensional Fund Advisors
00:10:00
investment thesis and current investment climate|Michael A. Rotgin,Partner and Chief Operating Officer,Shelter Capital
00:10:00
Castings PLC is the UK's premier iron casting and machining firm, supplying cast parts to the truck and automotive sectors.
00:10:00
Capella Minerals CEO Mary Kroth Discusses Strategic Gold and Copper Projects in Canada and Scandinavia, Upcoming Milestones, and Team Strength at Mining Conference

© 2026 Nehu